| 000 | 01363 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517170140.0 | ||
| 264 | 0 | _c20190909 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1435-1250 | ||
| 024 | 7 |
_a10.1007/s00393-017-0356-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShahin, A A | |
| 245 | 0 | 0 |
_aEfficacy and safety of sofosbuvir-based, interferon-free therapy : The Management of rheumatologic extrahepatic manifestations associated with chronic hepatitis C virus infection. _h[electronic resource] |
| 260 |
_bZeitschrift fur Rheumatologie _cSep 2018 |
||
| 300 |
_a621-628 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHepacivirus |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRheumatic Diseases _xcomplications |
| 650 | 0 | 4 |
_aSofosbuvir _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZayed, H S | |
| 700 | 1 | _aSaid, M | |
| 700 | 1 | _aAmer, S A | |
| 773 | 0 |
_tZeitschrift fur Rheumatologie _gvol. 77 _gno. 7 _gp. 621-628 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00393-017-0356-7 _zAvailable from publisher's website |
| 999 |
_c27452901 _d27452901 |
||